Darren Nolen of Nolen Ortho
Nolen Ortho is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Founder/Inventor Darren Nolen tells the story of his innovation’s journey from inspiration to the Challenge finals.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
Nolen Ortho develops next-generation tissue repair materials using our controlled activation technology: bone glue, osteoporosis repair, spinal fusion. Continue reading
This gallery contains 39 photos.
Last night, more than 200 attendees got a inside look at the future of medical device technology in Moloney Hall at UMass Lowell. Jennifer Griffin of Massachusetts Life Sciences Center delivered the opening remarks, saying, “The sense of community is … Continue reading
Alan Schneyer of Fairbanks Pharmaceuticals
Introducing Fairbanks Pharmaceuticals, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Alan Schneyer explains their innovation and shares the story of its development.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
Fairbanks Pharmaceuticals is developing a novel treatment for type 1 and type 2 diabetes that addresses the underlying cause of the disease. Continue reading
Muhammad Mujeeb- U-Rahman of Integrated Medical Sensors
Integrated Medical Sensors is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Muhammad Mujeeb-U-Rahman recounts the journey of their innovation from inspiration to development to the Challenge finals.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
IMS has developed the world’s smallest wireless glucose sensor that requires no calibration, is user-insertable, and works for 30 days or longer. Continue reading
ASG co-founders Marcie Black and Bill Rever
Advanced Silicon Group (ASG) is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. CEO Marcie Black told us the story behind their innovation and shared their vision for its future.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
ASG is enabling drug developers to measure the concentration of biomarkers in patients’ blood, giving an early indicator in clinical trials. Continue reading
Clockwise from top left: Christopher Locher, CEO/Co-Founder; Mark Duffy, CFO/COO; Kien Nguyen, Senior Director, Microbiology; David Putnam, Co-Founder; Matthew DeLisa, Co-Founder; Ly Phan, SVP, Portfolio Management & Preclinical Development
Meet Versatope, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. SVP Ly Phan described their innovation and shared the story behind its inspiration and development.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
An immuno-therapeutic and vaccine delivery platform made from probiotic exosomes (extracellular vesicles)—designed by nature and customized by Versatope to deliver immunity. Continue reading
Andy Kozminski and Michael Moore of MedKairos
MedKairos is one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Michael Moore explained their innovation and the story behind its inspiration and development.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
One out of five biopsies fails to return a diagnosis. Our technology intervenes during the procedure, so patients will only undergo the procedure once. Continue reading
Geeta Singh of MAG Optics
MAG Optics is one of 20 finalists in the 7th annual M2D2 $200K Challenge. Geeta Singh, Co-founder and Chief Business Officer, shares the story of their innovation.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
MAG Optics is pioneering an intra-corneal implant, MAGarcs, that is the first patient-centric corneal shape-changing platform to address keratoconus, a rare degenerative disease characterized by a cone-shaped cornea. Continue reading
The panel discussion will focus on innovation in spine surgery to improve clinical outcomes. Considering the complex spinal pathology, spine surgeons leverage different technologies and techniques to achieve a safe and efficacious clinical outcome. Researchers and clinicians with a multi-disciplinary background will share their scientific data with all spine specialists. Continue reading
Dr. Lindsey Lozeau and Todd E. Alexander of AMProtection
Introducing AMProtection, one of 20 medtech startups chosen as finalists in the 7th annual M2D2 $200K Challenge. Co-founder Todd Alexander shared the story of their innovation and its development so far.
What is the innovation you’ve entered in the M2D2 $200K Challenge?
AMProtection provides platform antimicrobial coatings to prevent medical device-associated infections without promoting bacterial resistance. Continue reading